Copper accumulation in the sequestrum of medication-related osteonecrosis of the jaw.
Sugiyama T, Uo M, Mizoguchi T, Wada T, Omagari D, Komiyama K, Mori Y.
Bone Rep. 2015 Aug 10;3:40-47. doi: 10.1016/j.bonr.2015.08.001. eCollection 2015 Dec.
Removal of a sequestrum by a patient with medication-related osteonecrosis of the jaw.
Davies M, Power A, Kanatas A.
Br J Oral Maxillofac Surg. 2017 Nov;55(9):980-981. doi: 10.1016/j.bjoms.2017.06.019. Epub 2017 Sep 28.
Next-generation sequencing analysis of bacterial species present in the sequestrum of medication-related osteonecrosis of the jaw patients.
Choi NR, Na HS, Han H, Chung J, Kim YD.
Arch Oral Biol. 2025 Apr;172:106180. doi: 10.1016/j.archoralbio.2025.106180. Epub 2025 Jan 21.
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw.
Ruan HJ, Chen H, Hou JS, An JG, Guo YX, Liu B, Tian L, Pan J, Li JS, Jiang CH, Tian Z, Xu J, Zhu L, Sun CF, Zhi KQ, Qu Q, Zong CL, Li MY, Zhang ZY, He Y.
J Bone Oncol. 2024 Nov 19;49:100650. doi: 10.1016/j.jbo.2024.100650. eCollection 2024 Dec.
Early removal of sequestrum in patients affected by medication-related osteonecrosis of the jaw.
Kharazmi M, Hallberg P.
Br J Oral Maxillofac Surg. 2018 Apr;56(3):237-238. doi: 10.1016/j.bjoms.2018.01.012.
Preventive effect of teriparatide on medication-related osteonecrosis of the jaw in rats.
Park KM, Lee N, Kim J, Kim HS, Park W.
Sci Rep. 2023 Sep 19;13(1):15518. doi: 10.1038/s41598-023-42607-y.
Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
Schoenhof R, Munz A, Yuan A, ElAyouti A, Boesmueller H, Blumenstock G, Reinert S, Hoefert S.
J Craniomaxillofac Surg. 2021 Jun;49(6):508-517. doi: 10.1016/j.jcms.2021.02.018. Epub 2021 Mar 2.
Ozone Infiltration for Osteonecrosis of the Jaw Therapy: A Case Series.
Di Fede O, Del Gaizo C, Panzarella V, La Mantia G, Tozzo P, Di Grigoli A, Lo Casto A, Mauceri R, Campisi G.
J Clin Med. 2022 Sep 9;11(18):5307. doi: 10.3390/jcm11185307.
Usability of surgical treatment in cases of bisphosphonate-related osteonecrosis of the jaw stage 2 with sequestrum.
Fukushima Y, Enoki Y, Nakaoka C, Okubo M, Kokabu S, Nojima J, Sato T, Yoda T.
Ann Maxillofac Surg. 2015 Jan-Jun;5(1):67-70. doi: 10.4103/2231-0746.161067.
Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
Sakamoto Y, Sawada S, Kojima Y.
Sci Rep. 2023 Aug 9;13(1):12890. doi: 10.1038/s41598-023-39755-6.
